Editas Medicine launches underwritten follow-on stock offering with warrants

Editas Medicine

Editas Medicine

EDIT

0.00
  • Editas Medicine launched an underwritten public offering of common stock or pre-funded warrants.
  • The deal includes accompanying warrants to buy common stock, with pre-funded warrants available in lieu of shares.
  • Cantor Fitzgerald and Wells Fargo Securities are joint book-running managers.
  • Pricing, size, and timing were not disclosed; completion depends on market conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Editas Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605260615PRIMZONEFULLFEED9726370) on May 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.